Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02966639 · ClinicalTrials.gov registry record

Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis

A clinical trial of Spondylolisthesis, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
171
Enrollment target
1
Study location

NCT02966639 is a study of Spondylolisthesis that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 171 participants, above the 143-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02966639, a study of Spondylolisthesis, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
171 participants
Enrollment target
1
Study location

Study Summary

The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according to the RAND Appropriateness Method (RAM) Criteria.

Conditions Studied

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2016-10
Est. Completion 2021-06-01

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT02966639

The ClinicalTrials.gov registry entry for NCT02966639 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 143-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (20% higher). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spondylolisthesis appearing as the primary indexed condition, and to 0 interventions.

NCT02966639 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT02966639 about?

NCT02966639 is a clinical study titled "Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis". The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according...

What is the current status of trial NCT02966639?

This trial is currently completed. The enrollment target is 171 participants. The study started on 2016-10. Estimated completion is 2021-06-01.

What conditions does trial NCT02966639 study?

This clinical trial studies the following conditions: Spondylolisthesis.

Who is sponsoring clinical trial NCT02966639?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02966639 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolisthesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.